nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—ADRA1A—Apraclonidine—glaucoma	0.0944	0.144	CbGbCtD
Escitalopram—CHRM1—Carbachol—glaucoma	0.0891	0.136	CbGbCtD
Escitalopram—CHRM1—Pilocarpine—glaucoma	0.0828	0.126	CbGbCtD
Escitalopram—ADRA1A—Dipivefrin—glaucoma	0.0755	0.115	CbGbCtD
Escitalopram—SLC6A2—Clonidine—glaucoma	0.0454	0.069	CbGbCtD
Escitalopram—ADRA1A—Clonidine—glaucoma	0.0392	0.0597	CbGbCtD
Escitalopram—CYP2D6—Carteolol—glaucoma	0.0367	0.0559	CbGbCtD
Escitalopram—CYP2D6—Betaxolol—glaucoma	0.0248	0.0378	CbGbCtD
Escitalopram—CYP2C19—Methazolamide—glaucoma	0.0247	0.0376	CbGbCtD
Escitalopram—CYP2C19—Timolol—glaucoma	0.021	0.032	CbGbCtD
Escitalopram—CYP2D6—Methazolamide—glaucoma	0.0188	0.0286	CbGbCtD
Escitalopram—CYP3A4—Pilocarpine—glaucoma	0.0177	0.0269	CbGbCtD
Escitalopram—CYP2D6—Timolol—glaucoma	0.016	0.0243	CbGbCtD
Escitalopram—CYP3A4—Brinzolamide—glaucoma	0.0139	0.0211	CbGbCtD
Escitalopram—CYP2D6—Clonidine—glaucoma	0.0136	0.0207	CbGbCtD
Escitalopram—CYP3A4—Dorzolamide—glaucoma	0.0134	0.0204	CbGbCtD
Escitalopram—CYP3A4—Methazolamide—glaucoma	0.012	0.0182	CbGbCtD
Escitalopram—CYP3A4—Acetazolamide—glaucoma	0.00956	0.0145	CbGbCtD
Escitalopram—CYP3A4—Clonidine—glaucoma	0.00865	0.0132	CbGbCtD
Escitalopram—SLC6A3—NRF2 pathway—GSTM1—glaucoma	9.55e-05	0.00228	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—PTGFR—glaucoma	9.48e-05	0.00226	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—PTGFR—glaucoma	9.45e-05	0.00225	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	9.3e-05	0.00222	CbGpPWpGaD
Escitalopram—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.24e-05	0.0022	CbGpPWpGaD
Escitalopram—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	9.21e-05	0.0022	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—FAS—glaucoma	8.7e-05	0.00208	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.51e-05	0.00203	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.54e-05	0.0018	CbGpPWpGaD
Escitalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.45e-05	0.00178	CbGpPWpGaD
Escitalopram—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.35e-05	0.00175	CbGpPWpGaD
Escitalopram—HTR2C—G alpha (q) signalling events—EDN1—glaucoma	7.21e-05	0.00172	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—NGFR—glaucoma	7e-05	0.00167	CbGpPWpGaD
Escitalopram—Feeling abnormal—Brinzolamide—glaucoma	6.94e-05	0.000231	CcSEcCtD
Escitalopram—Mental disorder—Betaxolol—glaucoma	6.94e-05	0.000231	CcSEcCtD
Escitalopram—Pain—Pilocarpine—glaucoma	6.92e-05	0.00023	CcSEcCtD
Escitalopram—Constipation—Pilocarpine—glaucoma	6.92e-05	0.00023	CcSEcCtD
Escitalopram—Cough—Clonidine—glaucoma	6.91e-05	0.00023	CcSEcCtD
Escitalopram—Sweating—Timolol—glaucoma	6.91e-05	0.00023	CcSEcCtD
Escitalopram—Dizziness—Apraclonidine—glaucoma	6.91e-05	0.00023	CcSEcCtD
Escitalopram—Erythema—Betaxolol—glaucoma	6.89e-05	0.000229	CcSEcCtD
Escitalopram—Malnutrition—Betaxolol—glaucoma	6.89e-05	0.000229	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—OPN4—glaucoma	6.86e-05	0.00164	CbGpPWpGaD
Escitalopram—Urticaria—Dorzolamide—glaucoma	6.8e-05	0.000226	CcSEcCtD
Escitalopram—Epistaxis—Timolol—glaucoma	6.8e-05	0.000226	CcSEcCtD
Escitalopram—Body temperature increased—Dorzolamide—glaucoma	6.77e-05	0.000225	CcSEcCtD
Escitalopram—Abdominal pain—Dorzolamide—glaucoma	6.77e-05	0.000225	CcSEcCtD
Escitalopram—Tension—Betaxolol—glaucoma	6.77e-05	0.000225	CcSEcCtD
Escitalopram—Sinusitis—Timolol—glaucoma	6.76e-05	0.000225	CcSEcCtD
Escitalopram—Dysgeusia—Betaxolol—glaucoma	6.75e-05	0.000224	CcSEcCtD
Escitalopram—Arthralgia—Clonidine—glaucoma	6.74e-05	0.000224	CcSEcCtD
Escitalopram—Chest pain—Clonidine—glaucoma	6.74e-05	0.000224	CcSEcCtD
Escitalopram—Abdominal pain—Travoprost—glaucoma	6.74e-05	0.000224	CcSEcCtD
Escitalopram—Agranulocytosis—Timolol—glaucoma	6.73e-05	0.000223	CcSEcCtD
Escitalopram—Anxiety—Clonidine—glaucoma	6.72e-05	0.000223	CcSEcCtD
Escitalopram—Asthenia—Acetazolamide—glaucoma	6.7e-05	0.000223	CcSEcCtD
Escitalopram—Dizziness—Bimatoprost—glaucoma	6.7e-05	0.000223	CcSEcCtD
Escitalopram—Nervousness—Betaxolol—glaucoma	6.7e-05	0.000223	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	6.7e-05	0.000222	CcSEcCtD
Escitalopram—CYP2C19—Biological oxidations—GSTT1—glaucoma	6.69e-05	0.0016	CbGpPWpGaD
Escitalopram—Urticaria—Brinzolamide—glaucoma	6.69e-05	0.000222	CcSEcCtD
Escitalopram—Feeling abnormal—Pilocarpine—glaucoma	6.67e-05	0.000222	CcSEcCtD
Escitalopram—Discomfort—Clonidine—glaucoma	6.66e-05	0.000221	CcSEcCtD
Escitalopram—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	6.65e-05	0.00159	CbGpPWpGaD
Escitalopram—Vomiting—Apraclonidine—glaucoma	6.64e-05	0.000221	CcSEcCtD
Escitalopram—Muscle spasms—Betaxolol—glaucoma	6.63e-05	0.00022	CcSEcCtD
Escitalopram—Gastrointestinal pain—Pilocarpine—glaucoma	6.62e-05	0.00022	CcSEcCtD
Escitalopram—Hypersensitivity—Brimonidine—glaucoma	6.61e-05	0.00022	CcSEcCtD
Escitalopram—Dry mouth—Clonidine—glaucoma	6.59e-05	0.000219	CcSEcCtD
Escitalopram—Bradycardia—Timolol—glaucoma	6.59e-05	0.000219	CcSEcCtD
Escitalopram—Dermatitis—Apraclonidine—glaucoma	6.58e-05	0.000219	CcSEcCtD
Escitalopram—Headache—Apraclonidine—glaucoma	6.54e-05	0.000217	CcSEcCtD
Escitalopram—Confusional state—Clonidine—glaucoma	6.52e-05	0.000217	CcSEcCtD
Escitalopram—Vision blurred—Betaxolol—glaucoma	6.5e-05	0.000216	CcSEcCtD
Escitalopram—Rhinitis—Timolol—glaucoma	6.49e-05	0.000216	CcSEcCtD
Escitalopram—Oedema—Clonidine—glaucoma	6.46e-05	0.000215	CcSEcCtD
Escitalopram—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	6.46e-05	0.00154	CbGpPWpGaD
Escitalopram—Tremor—Betaxolol—glaucoma	6.46e-05	0.000215	CcSEcCtD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	6.45e-05	0.00154	CbGpPWpGaD
Escitalopram—Hallucination—Timolol—glaucoma	6.44e-05	0.000214	CcSEcCtD
Escitalopram—Asthenia—Brimonidine—glaucoma	6.43e-05	0.000214	CcSEcCtD
Escitalopram—Infection—Clonidine—glaucoma	6.42e-05	0.000213	CcSEcCtD
Escitalopram—Body temperature increased—Pilocarpine—glaucoma	6.4e-05	0.000213	CcSEcCtD
Escitalopram—Abdominal pain—Pilocarpine—glaucoma	6.4e-05	0.000213	CcSEcCtD
Escitalopram—Ill-defined disorder—Betaxolol—glaucoma	6.4e-05	0.000213	CcSEcCtD
Escitalopram—Diarrhoea—Acetazolamide—glaucoma	6.39e-05	0.000212	CcSEcCtD
Escitalopram—Rash—Bimatoprost—glaucoma	6.39e-05	0.000212	CcSEcCtD
Escitalopram—Dermatitis—Bimatoprost—glaucoma	6.38e-05	0.000212	CcSEcCtD
Escitalopram—Oedema peripheral—Timolol—glaucoma	6.37e-05	0.000212	CcSEcCtD
Escitalopram—Anaemia—Betaxolol—glaucoma	6.37e-05	0.000212	CcSEcCtD
Escitalopram—Shock—Clonidine—glaucoma	6.36e-05	0.000211	CcSEcCtD
Escitalopram—Connective tissue disorder—Timolol—glaucoma	6.36e-05	0.000211	CcSEcCtD
Escitalopram—Pruritus—Brimonidine—glaucoma	6.35e-05	0.000211	CcSEcCtD
Escitalopram—Headache—Bimatoprost—glaucoma	6.35e-05	0.000211	CcSEcCtD
Escitalopram—Nervous system disorder—Clonidine—glaucoma	6.34e-05	0.000211	CcSEcCtD
Escitalopram—Thrombocytopenia—Clonidine—glaucoma	6.33e-05	0.00021	CcSEcCtD
Escitalopram—Hypersensitivity—Dorzolamide—glaucoma	6.31e-05	0.00021	CcSEcCtD
Escitalopram—Tachycardia—Clonidine—glaucoma	6.31e-05	0.00021	CcSEcCtD
Escitalopram—Hypersensitivity—Travoprost—glaucoma	6.28e-05	0.000209	CcSEcCtD
Escitalopram—Skin disorder—Clonidine—glaucoma	6.28e-05	0.000209	CcSEcCtD
Escitalopram—Hyperhidrosis—Clonidine—glaucoma	6.25e-05	0.000208	CcSEcCtD
Escitalopram—HRH1—G alpha (q) signalling events—EDN1—glaucoma	6.25e-05	0.00149	CbGpPWpGaD
Escitalopram—Visual impairment—Timolol—glaucoma	6.24e-05	0.000207	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—OPN4—glaucoma	6.23e-05	0.00149	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.23e-05	0.00149	CbGpPWpGaD
Escitalopram—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	6.23e-05	0.00149	CbGpPWpGaD
Escitalopram—Malaise—Betaxolol—glaucoma	6.22e-05	0.000207	CcSEcCtD
Escitalopram—Nausea—Apraclonidine—glaucoma	6.21e-05	0.000206	CcSEcCtD
Escitalopram—Hypersensitivity—Brinzolamide—glaucoma	6.2e-05	0.000206	CcSEcCtD
Escitalopram—Vertigo—Betaxolol—glaucoma	6.19e-05	0.000206	CcSEcCtD
Escitalopram—Syncope—Betaxolol—glaucoma	6.18e-05	0.000205	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—PTGFR—glaucoma	6.18e-05	0.00148	CbGpPWpGaD
Escitalopram—Dizziness—Acetazolamide—glaucoma	6.18e-05	0.000205	CcSEcCtD
Escitalopram—Anorexia—Clonidine—glaucoma	6.16e-05	0.000205	CcSEcCtD
Escitalopram—CYP2D6—Biological oxidations—GSTT1—glaucoma	6.16e-05	0.00147	CbGpPWpGaD
Escitalopram—Asthenia—Dorzolamide—glaucoma	6.15e-05	0.000204	CcSEcCtD
Escitalopram—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	6.13e-05	0.00146	CbGpPWpGaD
Escitalopram—Asthenia—Travoprost—glaucoma	6.12e-05	0.000203	CcSEcCtD
Escitalopram—Palpitations—Betaxolol—glaucoma	6.09e-05	0.000202	CcSEcCtD
Escitalopram—Pruritus—Dorzolamide—glaucoma	6.06e-05	0.000201	CcSEcCtD
Escitalopram—Loss of consciousness—Betaxolol—glaucoma	6.06e-05	0.000201	CcSEcCtD
Escitalopram—Eye disorder—Timolol—glaucoma	6.05e-05	0.000201	CcSEcCtD
Escitalopram—Asthenia—Brinzolamide—glaucoma	6.04e-05	0.000201	CcSEcCtD
Escitalopram—Hypotension—Clonidine—glaucoma	6.04e-05	0.000201	CcSEcCtD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.04e-05	0.00144	CbGpPWpGaD
Escitalopram—Pruritus—Travoprost—glaucoma	6.03e-05	0.0002	CcSEcCtD
Escitalopram—Tinnitus—Timolol—glaucoma	6.03e-05	0.0002	CcSEcCtD
Escitalopram—Cough—Betaxolol—glaucoma	6.02e-05	0.0002	CcSEcCtD
Escitalopram—Nausea—Bimatoprost—glaucoma	6.02e-05	0.0002	CcSEcCtD
Escitalopram—Cardiac disorder—Timolol—glaucoma	6e-05	0.0002	CcSEcCtD
Escitalopram—Hypersensitivity—Pilocarpine—glaucoma	5.96e-05	0.000198	CcSEcCtD
Escitalopram—Pruritus—Brinzolamide—glaucoma	5.96e-05	0.000198	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—OPN4—glaucoma	5.95e-05	0.00142	CbGpPWpGaD
Escitalopram—Vomiting—Acetazolamide—glaucoma	5.94e-05	0.000197	CcSEcCtD
Escitalopram—Dizziness—Brimonidine—glaucoma	5.93e-05	0.000197	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—OPN4—glaucoma	5.93e-05	0.00142	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Clonidine—glaucoma	5.89e-05	0.000196	CcSEcCtD
Escitalopram—Angiopathy—Timolol—glaucoma	5.87e-05	0.000195	CcSEcCtD
Escitalopram—Myalgia—Betaxolol—glaucoma	5.87e-05	0.000195	CcSEcCtD
Escitalopram—Arthralgia—Betaxolol—glaucoma	5.87e-05	0.000195	CcSEcCtD
Escitalopram—Chest pain—Betaxolol—glaucoma	5.87e-05	0.000195	CcSEcCtD
Escitalopram—Diarrhoea—Dorzolamide—glaucoma	5.86e-05	0.000195	CcSEcCtD
Escitalopram—Headache—Acetazolamide—glaucoma	5.85e-05	0.000195	CcSEcCtD
Escitalopram—Anxiety—Betaxolol—glaucoma	5.85e-05	0.000194	CcSEcCtD
Escitalopram—Insomnia—Clonidine—glaucoma	5.85e-05	0.000194	CcSEcCtD
Escitalopram—Immune system disorder—Timolol—glaucoma	5.84e-05	0.000194	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	5.84e-05	0.00139	CbGpPWpGaD
Escitalopram—Diarrhoea—Travoprost—glaucoma	5.83e-05	0.000194	CcSEcCtD
Escitalopram—Mediastinal disorder—Timolol—glaucoma	5.83e-05	0.000194	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	5.83e-05	0.000194	CcSEcCtD
Escitalopram—Asthenia—Pilocarpine—glaucoma	5.81e-05	0.000193	CcSEcCtD
Escitalopram—Paraesthesia—Clonidine—glaucoma	5.8e-05	0.000193	CcSEcCtD
Escitalopram—Discomfort—Betaxolol—glaucoma	5.8e-05	0.000193	CcSEcCtD
Escitalopram—Arrhythmia—Timolol—glaucoma	5.78e-05	0.000192	CcSEcCtD
Escitalopram—Dyspnoea—Clonidine—glaucoma	5.76e-05	0.000191	CcSEcCtD
Escitalopram—Diarrhoea—Brinzolamide—glaucoma	5.76e-05	0.000191	CcSEcCtD
Escitalopram—Somnolence—Clonidine—glaucoma	5.75e-05	0.000191	CcSEcCtD
Escitalopram—Dry mouth—Betaxolol—glaucoma	5.74e-05	0.000191	CcSEcCtD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	5.73e-05	0.00137	CbGpPWpGaD
Escitalopram—Pruritus—Pilocarpine—glaucoma	5.73e-05	0.00019	CcSEcCtD
Escitalopram—Alopecia—Timolol—glaucoma	5.72e-05	0.00019	CcSEcCtD
Escitalopram—Confusional state—Betaxolol—glaucoma	5.67e-05	0.000189	CcSEcCtD
Escitalopram—Mental disorder—Timolol—glaucoma	5.67e-05	0.000188	CcSEcCtD
Escitalopram—Dizziness—Dorzolamide—glaucoma	5.66e-05	0.000188	CcSEcCtD
Escitalopram—Rash—Brimonidine—glaucoma	5.65e-05	0.000188	CcSEcCtD
Escitalopram—Dermatitis—Brimonidine—glaucoma	5.65e-05	0.000188	CcSEcCtD
Escitalopram—Dizziness—Travoprost—glaucoma	5.64e-05	0.000187	CcSEcCtD
Escitalopram—Erythema—Timolol—glaucoma	5.63e-05	0.000187	CcSEcCtD
Escitalopram—Malnutrition—Timolol—glaucoma	5.63e-05	0.000187	CcSEcCtD
Escitalopram—Oedema—Betaxolol—glaucoma	5.63e-05	0.000187	CcSEcCtD
Escitalopram—Headache—Brimonidine—glaucoma	5.62e-05	0.000187	CcSEcCtD
Escitalopram—Decreased appetite—Clonidine—glaucoma	5.62e-05	0.000187	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—PTGFR—glaucoma	5.61e-05	0.00134	CbGpPWpGaD
Escitalopram—Infection—Betaxolol—glaucoma	5.59e-05	0.000186	CcSEcCtD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.59e-05	0.00133	CbGpPWpGaD
Escitalopram—Gastrointestinal disorder—Clonidine—glaucoma	5.58e-05	0.000185	CcSEcCtD
Escitalopram—Fatigue—Clonidine—glaucoma	5.57e-05	0.000185	CcSEcCtD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.57e-05	0.00133	CbGpPWpGaD
Escitalopram—Dizziness—Brinzolamide—glaucoma	5.57e-05	0.000185	CcSEcCtD
Escitalopram—Nausea—Acetazolamide—glaucoma	5.55e-05	0.000184	CcSEcCtD
Escitalopram—Diarrhoea—Pilocarpine—glaucoma	5.54e-05	0.000184	CcSEcCtD
Escitalopram—Shock—Betaxolol—glaucoma	5.54e-05	0.000184	CcSEcCtD
Escitalopram—Tension—Timolol—glaucoma	5.53e-05	0.000184	CcSEcCtD
Escitalopram—Constipation—Clonidine—glaucoma	5.53e-05	0.000184	CcSEcCtD
Escitalopram—Pain—Clonidine—glaucoma	5.53e-05	0.000184	CcSEcCtD
Escitalopram—Nervous system disorder—Betaxolol—glaucoma	5.52e-05	0.000183	CcSEcCtD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.52e-05	0.00132	CbGpPWpGaD
Escitalopram—Dysgeusia—Timolol—glaucoma	5.52e-05	0.000183	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—SMO—glaucoma	5.51e-05	0.00132	CbGpPWpGaD
Escitalopram—Thrombocytopenia—Betaxolol—glaucoma	5.51e-05	0.000183	CcSEcCtD
Escitalopram—Tachycardia—Betaxolol—glaucoma	5.49e-05	0.000182	CcSEcCtD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.48e-05	0.00131	CbGpPWpGaD
Escitalopram—Nervousness—Timolol—glaucoma	5.47e-05	0.000182	CcSEcCtD
Escitalopram—Skin disorder—Betaxolol—glaucoma	5.47e-05	0.000182	CcSEcCtD
Escitalopram—Vomiting—Dorzolamide—glaucoma	5.45e-05	0.000181	CcSEcCtD
Escitalopram—Hyperhidrosis—Betaxolol—glaucoma	5.44e-05	0.000181	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—OPN4—glaucoma	5.4e-05	0.00129	CbGpPWpGaD
Escitalopram—Rash—Dorzolamide—glaucoma	5.4e-05	0.000179	CcSEcCtD
Escitalopram—Dermatitis—Dorzolamide—glaucoma	5.4e-05	0.000179	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—OPN4—glaucoma	5.38e-05	0.00129	CbGpPWpGaD
Escitalopram—Rash—Travoprost—glaucoma	5.38e-05	0.000179	CcSEcCtD
Escitalopram—Dermatitis—Travoprost—glaucoma	5.37e-05	0.000179	CcSEcCtD
Escitalopram—Headache—Dorzolamide—glaucoma	5.37e-05	0.000178	CcSEcCtD
Escitalopram—Anorexia—Betaxolol—glaucoma	5.36e-05	0.000178	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—PTGFR—glaucoma	5.36e-05	0.00128	CbGpPWpGaD
Escitalopram—Vomiting—Brinzolamide—glaucoma	5.35e-05	0.000178	CcSEcCtD
Escitalopram—Dizziness—Pilocarpine—glaucoma	5.35e-05	0.000178	CcSEcCtD
Escitalopram—Headache—Travoprost—glaucoma	5.34e-05	0.000178	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	5.34e-05	0.00127	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—CYP1B1—glaucoma	5.33e-05	0.00127	CbGpPWpGaD
Escitalopram—Nausea—Brimonidine—glaucoma	5.33e-05	0.000177	CcSEcCtD
Escitalopram—Feeling abnormal—Clonidine—glaucoma	5.33e-05	0.000177	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—LRP12—glaucoma	5.31e-05	0.00127	CbGpPWpGaD
Escitalopram—Rash—Brinzolamide—glaucoma	5.31e-05	0.000176	CcSEcCtD
Escitalopram—Vision blurred—Timolol—glaucoma	5.31e-05	0.000176	CcSEcCtD
Escitalopram—Dermatitis—Brinzolamide—glaucoma	5.3e-05	0.000176	CcSEcCtD
Escitalopram—ADRA1A—Signaling by GPCR—OPN4—glaucoma	5.3e-05	0.00127	CbGpPWpGaD
Escitalopram—Gastrointestinal pain—Clonidine—glaucoma	5.28e-05	0.000176	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.28e-05	0.00126	CbGpPWpGaD
Escitalopram—Headache—Brinzolamide—glaucoma	5.28e-05	0.000175	CcSEcCtD
Escitalopram—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	5.26e-05	0.00126	CbGpPWpGaD
Escitalopram—Hypotension—Betaxolol—glaucoma	5.26e-05	0.000175	CcSEcCtD
Escitalopram—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	5.25e-05	0.00125	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—FAS—glaucoma	5.21e-05	0.00124	CbGpPWpGaD
Escitalopram—Angioedema—Timolol—glaucoma	5.15e-05	0.000171	CcSEcCtD
Escitalopram—Vomiting—Pilocarpine—glaucoma	5.15e-05	0.000171	CcSEcCtD
Escitalopram—Urticaria—Clonidine—glaucoma	5.13e-05	0.000171	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Betaxolol—glaucoma	5.13e-05	0.00017	CcSEcCtD
Escitalopram—Abdominal pain—Clonidine—glaucoma	5.11e-05	0.00017	CcSEcCtD
Escitalopram—Body temperature increased—Clonidine—glaucoma	5.11e-05	0.00017	CcSEcCtD
Escitalopram—Rash—Pilocarpine—glaucoma	5.1e-05	0.00017	CcSEcCtD
Escitalopram—Dermatitis—Pilocarpine—glaucoma	5.1e-05	0.000169	CcSEcCtD
Escitalopram—Insomnia—Betaxolol—glaucoma	5.09e-05	0.000169	CcSEcCtD
Escitalopram—Nausea—Dorzolamide—glaucoma	5.09e-05	0.000169	CcSEcCtD
Escitalopram—Headache—Pilocarpine—glaucoma	5.07e-05	0.000168	CcSEcCtD
Escitalopram—Nausea—Travoprost—glaucoma	5.07e-05	0.000168	CcSEcCtD
Escitalopram—Vertigo—Timolol—glaucoma	5.06e-05	0.000168	CcSEcCtD
Escitalopram—Paraesthesia—Betaxolol—glaucoma	5.05e-05	0.000168	CcSEcCtD
Escitalopram—Syncope—Timolol—glaucoma	5.05e-05	0.000168	CcSEcCtD
Escitalopram—Dyspnoea—Betaxolol—glaucoma	5.02e-05	0.000167	CcSEcCtD
Escitalopram—Nausea—Brinzolamide—glaucoma	5e-05	0.000166	CcSEcCtD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.98e-05	0.00119	CbGpPWpGaD
Escitalopram—Palpitations—Timolol—glaucoma	4.98e-05	0.000165	CcSEcCtD
Escitalopram—Dyspepsia—Betaxolol—glaucoma	4.95e-05	0.000165	CcSEcCtD
Escitalopram—Loss of consciousness—Timolol—glaucoma	4.95e-05	0.000164	CcSEcCtD
Escitalopram—Cough—Timolol—glaucoma	4.91e-05	0.000163	CcSEcCtD
Escitalopram—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.91e-05	0.00117	CbGpPWpGaD
Escitalopram—Decreased appetite—Betaxolol—glaucoma	4.89e-05	0.000163	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—PTGFR—glaucoma	4.86e-05	0.00116	CbGpPWpGaD
Escitalopram—Hypertension—Timolol—glaucoma	4.86e-05	0.000162	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Betaxolol—glaucoma	4.86e-05	0.000161	CcSEcCtD
Escitalopram—Fatigue—Betaxolol—glaucoma	4.85e-05	0.000161	CcSEcCtD
Escitalopram—CHRM1—Signaling by GPCR—PTGFR—glaucoma	4.85e-05	0.00116	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	4.84e-05	0.00116	CbGpPWpGaD
Escitalopram—Pain—Betaxolol—glaucoma	4.81e-05	0.00016	CcSEcCtD
Escitalopram—Constipation—Betaxolol—glaucoma	4.81e-05	0.00016	CcSEcCtD
Escitalopram—Nausea—Pilocarpine—glaucoma	4.81e-05	0.00016	CcSEcCtD
Escitalopram—Myalgia—Timolol—glaucoma	4.8e-05	0.000159	CcSEcCtD
Escitalopram—Chest pain—Timolol—glaucoma	4.8e-05	0.000159	CcSEcCtD
Escitalopram—Arthralgia—Timolol—glaucoma	4.8e-05	0.000159	CcSEcCtD
Escitalopram—Anxiety—Timolol—glaucoma	4.78e-05	0.000159	CcSEcCtD
Escitalopram—HRH1—GPCR ligand binding—SMO—glaucoma	4.78e-05	0.00114	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.77e-05	0.00114	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	4.77e-05	0.00114	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—SMO—glaucoma	4.76e-05	0.00114	CbGpPWpGaD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	4.76e-05	0.000158	CcSEcCtD
Escitalopram—Hypersensitivity—Clonidine—glaucoma	4.76e-05	0.000158	CcSEcCtD
Escitalopram—Discomfort—Timolol—glaucoma	4.74e-05	0.000157	CcSEcCtD
Escitalopram—CYP2C19—Metabolism—CA5A—glaucoma	4.69e-05	0.00112	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NARFL—glaucoma	4.69e-05	0.00112	CbGpPWpGaD
Escitalopram—Dry mouth—Timolol—glaucoma	4.69e-05	0.000156	CcSEcCtD
Escitalopram—ADRA1A—GPCR ligand binding—SMO—glaucoma	4.69e-05	0.00112	CbGpPWpGaD
Escitalopram—Asthenia—Clonidine—glaucoma	4.64e-05	0.000154	CcSEcCtD
Escitalopram—Feeling abnormal—Betaxolol—glaucoma	4.64e-05	0.000154	CcSEcCtD
Escitalopram—Confusional state—Timolol—glaucoma	4.63e-05	0.000154	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—LRP12—glaucoma	4.6e-05	0.0011	CbGpPWpGaD
Escitalopram—Anaphylactic shock—Timolol—glaucoma	4.6e-05	0.000153	CcSEcCtD
Escitalopram—Oedema—Timolol—glaucoma	4.6e-05	0.000153	CcSEcCtD
Escitalopram—CHRM1—Signaling Pathways—LRP12—glaucoma	4.59e-05	0.0011	CbGpPWpGaD
Escitalopram—Pruritus—Clonidine—glaucoma	4.57e-05	0.000152	CcSEcCtD
Escitalopram—Infection—Timolol—glaucoma	4.57e-05	0.000152	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	4.52e-05	0.00108	CbGpPWpGaD
Escitalopram—Shock—Timolol—glaucoma	4.52e-05	0.00015	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—LRP12—glaucoma	4.52e-05	0.00108	CbGpPWpGaD
Escitalopram—ADRA1A—AMPK Signaling—TP53—glaucoma	4.51e-05	0.00108	CbGpPWpGaD
Escitalopram—Nervous system disorder—Timolol—glaucoma	4.51e-05	0.00015	CcSEcCtD
Escitalopram—Urticaria—Betaxolol—glaucoma	4.47e-05	0.000149	CcSEcCtD
Escitalopram—Skin disorder—Timolol—glaucoma	4.46e-05	0.000148	CcSEcCtD
Escitalopram—Body temperature increased—Betaxolol—glaucoma	4.45e-05	0.000148	CcSEcCtD
Escitalopram—Hyperhidrosis—Timolol—glaucoma	4.44e-05	0.000148	CcSEcCtD
Escitalopram—Diarrhoea—Clonidine—glaucoma	4.42e-05	0.000147	CcSEcCtD
Escitalopram—Anorexia—Timolol—glaucoma	4.38e-05	0.000146	CcSEcCtD
Escitalopram—CYP2D6—Metabolism—NARFL—glaucoma	4.32e-05	0.00103	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CA5A—glaucoma	4.32e-05	0.00103	CbGpPWpGaD
Escitalopram—Hypotension—Timolol—glaucoma	4.3e-05	0.000143	CcSEcCtD
Escitalopram—Dizziness—Clonidine—glaucoma	4.27e-05	0.000142	CcSEcCtD
Escitalopram—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.26e-05	0.00102	CbGpPWpGaD
Escitalopram—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.21e-05	0.001	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Timolol—glaucoma	4.19e-05	0.000139	CcSEcCtD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.17e-05	0.000996	CbGpPWpGaD
Escitalopram—Insomnia—Timolol—glaucoma	4.16e-05	0.000138	CcSEcCtD
Escitalopram—Hypersensitivity—Betaxolol—glaucoma	4.15e-05	0.000138	CcSEcCtD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.14e-05	0.000988	CbGpPWpGaD
Escitalopram—Paraesthesia—Timolol—glaucoma	4.13e-05	0.000137	CcSEcCtD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.12e-05	0.000984	CbGpPWpGaD
Escitalopram—Vomiting—Clonidine—glaucoma	4.11e-05	0.000137	CcSEcCtD
Escitalopram—Dyspnoea—Timolol—glaucoma	4.1e-05	0.000136	CcSEcCtD
Escitalopram—Somnolence—Timolol—glaucoma	4.09e-05	0.000136	CcSEcCtD
Escitalopram—Rash—Clonidine—glaucoma	4.08e-05	0.000135	CcSEcCtD
Escitalopram—Dermatitis—Clonidine—glaucoma	4.07e-05	0.000135	CcSEcCtD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.06e-05	0.000969	CbGpPWpGaD
Escitalopram—Headache—Clonidine—glaucoma	4.05e-05	0.000135	CcSEcCtD
Escitalopram—Dyspepsia—Timolol—glaucoma	4.05e-05	0.000134	CcSEcCtD
Escitalopram—Asthenia—Betaxolol—glaucoma	4.04e-05	0.000134	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.03e-05	0.000961	CbGpPWpGaD
Escitalopram—Decreased appetite—Timolol—glaucoma	4e-05	0.000133	CcSEcCtD
Escitalopram—Pruritus—Betaxolol—glaucoma	3.98e-05	0.000132	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Timolol—glaucoma	3.97e-05	0.000132	CcSEcCtD
Escitalopram—Fatigue—Timolol—glaucoma	3.96e-05	0.000132	CcSEcCtD
Escitalopram—Pain—Timolol—glaucoma	3.93e-05	0.000131	CcSEcCtD
Escitalopram—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.92e-05	0.000936	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.87e-05	0.000923	CbGpPWpGaD
Escitalopram—Diarrhoea—Betaxolol—glaucoma	3.85e-05	0.000128	CcSEcCtD
Escitalopram—Nausea—Clonidine—glaucoma	3.84e-05	0.000128	CcSEcCtD
Escitalopram—Feeling abnormal—Timolol—glaucoma	3.79e-05	0.000126	CcSEcCtD
Escitalopram—Gastrointestinal pain—Timolol—glaucoma	3.76e-05	0.000125	CcSEcCtD
Escitalopram—Dizziness—Betaxolol—glaucoma	3.72e-05	0.000124	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—OPN4—glaucoma	3.68e-05	0.000879	CbGpPWpGaD
Escitalopram—Urticaria—Timolol—glaucoma	3.65e-05	0.000121	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—EDN1—glaucoma	3.64e-05	0.000868	CbGpPWpGaD
Escitalopram—Abdominal pain—Timolol—glaucoma	3.63e-05	0.000121	CcSEcCtD
Escitalopram—Body temperature increased—Timolol—glaucoma	3.63e-05	0.000121	CcSEcCtD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.61e-05	0.000863	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.6e-05	0.00086	CbGpPWpGaD
Escitalopram—Vomiting—Betaxolol—glaucoma	3.58e-05	0.000119	CcSEcCtD
Escitalopram—Rash—Betaxolol—glaucoma	3.55e-05	0.000118	CcSEcCtD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.55e-05	0.000847	CbGpPWpGaD
Escitalopram—Dermatitis—Betaxolol—glaucoma	3.54e-05	0.000118	CcSEcCtD
Escitalopram—Headache—Betaxolol—glaucoma	3.52e-05	0.000117	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—HEYL—glaucoma	3.42e-05	0.000817	CbGpPWpGaD
Escitalopram—Hypersensitivity—Timolol—glaucoma	3.39e-05	0.000113	CcSEcCtD
Escitalopram—Nausea—Betaxolol—glaucoma	3.34e-05	0.000111	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—PTGFR—glaucoma	3.32e-05	0.000791	CbGpPWpGaD
Escitalopram—Asthenia—Timolol—glaucoma	3.3e-05	0.00011	CcSEcCtD
Escitalopram—SLC6A4—Circadian rythm related genes—TP53—glaucoma	3.26e-05	0.000777	CbGpPWpGaD
Escitalopram—Pruritus—Timolol—glaucoma	3.25e-05	0.000108	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.21e-05	0.000766	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OPN4—glaucoma	3.19e-05	0.000762	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OPN4—glaucoma	3.18e-05	0.000759	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—C3—glaucoma	3.18e-05	0.000758	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.16e-05	0.000755	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—EDN1—glaucoma	3.15e-05	0.000752	CbGpPWpGaD
Escitalopram—Diarrhoea—Timolol—glaucoma	3.15e-05	0.000105	CcSEcCtD
Escitalopram—CHRM1—GPCR ligand binding—EDN1—glaucoma	3.14e-05	0.00075	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OPN4—glaucoma	3.13e-05	0.000747	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—EDN1—glaucoma	3.09e-05	0.000738	CbGpPWpGaD
Escitalopram—Dizziness—Timolol—glaucoma	3.04e-05	0.000101	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—HEYL—glaucoma	2.97e-05	0.000708	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HEYL—glaucoma	2.96e-05	0.000706	CbGpPWpGaD
Escitalopram—Vomiting—Timolol—glaucoma	2.92e-05	9.71e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—HEYL—glaucoma	2.91e-05	0.000695	CbGpPWpGaD
Escitalopram—Rash—Timolol—glaucoma	2.9e-05	9.63e-05	CcSEcCtD
Escitalopram—Dermatitis—Timolol—glaucoma	2.9e-05	9.62e-05	CcSEcCtD
Escitalopram—Headache—Timolol—glaucoma	2.88e-05	9.57e-05	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—PTGFR—glaucoma	2.87e-05	0.000686	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTGFR—glaucoma	2.86e-05	0.000684	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—SMO—glaucoma	2.83e-05	0.000676	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NARFL—glaucoma	2.82e-05	0.000674	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CA5A—glaucoma	2.82e-05	0.000674	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.82e-05	0.000673	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—C3—glaucoma	2.75e-05	0.000657	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—C3—glaucoma	2.74e-05	0.000655	CbGpPWpGaD
Escitalopram—Nausea—Timolol—glaucoma	2.73e-05	9.07e-05	CcSEcCtD
Escitalopram—ADRA1A—GPCR ligand binding—C3—glaucoma	2.7e-05	0.000645	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RPTOR—glaucoma	2.59e-05	0.000619	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.56e-05	0.000612	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.53e-05	0.000604	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NCK2—glaucoma	2.51e-05	0.0006	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—SMO—glaucoma	2.45e-05	0.000585	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—SMO—glaucoma	2.44e-05	0.000584	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—SMO—glaucoma	2.41e-05	0.000574	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CA1—glaucoma	2.29e-05	0.000547	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RPTOR—glaucoma	2.25e-05	0.000537	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RPTOR—glaucoma	2.24e-05	0.000535	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CTSA—glaucoma	2.22e-05	0.00053	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RPTOR—glaucoma	2.21e-05	0.000527	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NCK2—glaucoma	2.18e-05	0.00052	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NCK2—glaucoma	2.17e-05	0.000518	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NCK2—glaucoma	2.14e-05	0.00051	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HDAC9—glaucoma	2.14e-05	0.00051	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CA1—glaucoma	2.11e-05	0.000503	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CA2—glaucoma	2.1e-05	0.0005	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—EDN1—glaucoma	2.05e-05	0.00049	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.05e-05	0.000489	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.05e-05	0.000489	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CTSA—glaucoma	2.04e-05	0.000487	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.95e-05	0.000465	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CA2—glaucoma	1.93e-05	0.00046	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EDN1—glaucoma	1.87e-05	0.000445	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HDAC9—glaucoma	1.85e-05	0.000442	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.85e-05	0.000441	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.82e-05	0.000434	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—C3—glaucoma	1.79e-05	0.000428	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—EDN1—glaucoma	1.78e-05	0.000425	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.77e-05	0.000424	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.75e-05	0.000417	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SMO—glaucoma	1.67e-05	0.000399	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—C3—glaucoma	1.63e-05	0.000389	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EDN1—glaucoma	1.62e-05	0.000386	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.61e-05	0.000385	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.59e-05	0.000379	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—C3—glaucoma	1.56e-05	0.000371	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—C3—glaucoma	1.55e-05	0.00037	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK2—glaucoma	1.53e-05	0.000365	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.53e-05	0.000364	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TXN—glaucoma	1.48e-05	0.000353	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SMO—glaucoma	1.45e-05	0.000346	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SMO—glaucoma	1.44e-05	0.000345	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SMO—glaucoma	1.42e-05	0.000339	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—C3—glaucoma	1.41e-05	0.000337	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—C3—glaucoma	1.41e-05	0.000336	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—C3—glaucoma	1.39e-05	0.000331	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CA1—glaucoma	1.38e-05	0.000329	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TXN—glaucoma	1.36e-05	0.000324	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.35e-05	0.000322	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.33e-05	0.000319	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CTSA—glaucoma	1.33e-05	0.000319	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000316	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.000315	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGFR—glaucoma	1.31e-05	0.000313	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.3e-05	0.00031	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CA2—glaucoma	1.26e-05	0.000301	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK1—glaucoma	1.25e-05	0.000298	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN2B—glaucoma	1.15e-05	0.000274	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTT1—glaucoma	1.14e-05	0.000273	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGFR—glaucoma	1.14e-05	0.000271	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGFR—glaucoma	1.13e-05	0.00027	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGFR—glaucoma	1.12e-05	0.000266	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EDN1—glaucoma	1.1e-05	0.000263	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000258	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000257	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK1—glaucoma	1.06e-05	0.000253	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTT1—glaucoma	1.05e-05	0.000251	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGF—glaucoma	1.01e-05	0.000242	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN2B—glaucoma	9.95e-06	0.000238	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN2B—glaucoma	9.92e-06	0.000237	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	9.77e-06	0.000233	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—C3—glaucoma	9.63e-06	0.00023	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EDN1—glaucoma	9.55e-06	0.000228	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EDN1—glaucoma	9.52e-06	0.000227	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EDN1—glaucoma	9.37e-06	0.000224	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.23e-06	0.00022	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1B1—glaucoma	9.12e-06	0.000218	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCA1—glaucoma	9.12e-06	0.000218	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—glaucoma	8.96e-06	0.000214	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CAV1—glaucoma	8.88e-06	0.000212	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TXN—glaucoma	8.88e-06	0.000212	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGF—glaucoma	8.78e-06	0.00021	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGF—glaucoma	8.75e-06	0.000209	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGF—glaucoma	8.61e-06	0.000206	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FN1—glaucoma	8.45e-06	0.000202	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1B1—glaucoma	8.39e-06	0.0002	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—glaucoma	8.39e-06	0.0002	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—BAD—glaucoma	8.35e-06	0.000199	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—C3—glaucoma	8.34e-06	0.000199	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—C3—glaucoma	8.32e-06	0.000199	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—C3—glaucoma	8.19e-06	0.000195	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—glaucoma	7.77e-06	0.000185	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—glaucoma	7.74e-06	0.000185	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CAV1—glaucoma	7.7e-06	0.000184	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CAV1—glaucoma	7.67e-06	0.000183	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—glaucoma	7.62e-06	0.000182	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CAV1—glaucoma	7.55e-06	0.00018	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FN1—glaucoma	7.32e-06	0.000175	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FN1—glaucoma	7.3e-06	0.000174	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—glaucoma	7.29e-06	0.000174	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—BAD—glaucoma	7.24e-06	0.000173	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—BAD—glaucoma	7.21e-06	0.000172	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FN1—glaucoma	7.19e-06	0.000172	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—BAD—glaucoma	7.1e-06	0.00017	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTT1—glaucoma	6.88e-06	0.000164	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—glaucoma	6.72e-06	0.00016	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—glaucoma	6.71e-06	0.00016	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—glaucoma	6.45e-06	0.000154	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—glaucoma	6e-06	0.000143	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAV1—glaucoma	5.94e-06	0.000142	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—glaucoma	5.93e-06	0.000142	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—glaucoma	5.82e-06	0.000139	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN1B—glaucoma	5.82e-06	0.000139	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—glaucoma	5.8e-06	0.000138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—glaucoma	5.71e-06	0.000136	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—glaucoma	5.52e-06	0.000132	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—glaucoma	5.49e-06	0.000131	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1B1—glaucoma	5.49e-06	0.000131	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAV1—glaucoma	5.47e-06	0.000131	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—glaucoma	5.39e-06	0.000129	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN1B—glaucoma	5.04e-06	0.00012	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN1B—glaucoma	5.02e-06	0.00012	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	4.95e-06	0.000118	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—glaucoma	4.84e-06	0.000115	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—glaucoma	4.67e-06	0.000111	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—glaucoma	4.65e-06	0.000111	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—glaucoma	4.58e-06	0.000109	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—glaucoma	4.5e-06	0.000107	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—glaucoma	4.39e-06	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—glaucoma	4.19e-06	0.0001	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—glaucoma	4.18e-06	9.98e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—glaucoma	4.13e-06	9.87e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—glaucoma	4.11e-06	9.82e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—glaucoma	4.11e-06	9.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—glaucoma	3.88e-06	9.25e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—glaucoma	3.78e-06	9.03e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—glaucoma	3.66e-06	8.73e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—glaucoma	3.61e-06	8.61e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAV1—glaucoma	3.57e-06	8.53e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—glaucoma	3.17e-06	7.56e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—glaucoma	3.16e-06	7.54e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—glaucoma	3.11e-06	7.42e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—glaucoma	2.7e-06	6.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—glaucoma	2.47e-06	5.9e-05	CbGpPWpGaD
